VYCO
Vycor Medical Inc
$0.06
+0.00 (+0.00%)
At close · Jul 8
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions, among others, raise substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$2.10M
Shares
33,372,796
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.06
Open$0.06
Day$0.06–0.06
52W$0.03–0.20
Avg vol 30d4K
Short int8K · 0.0% float · 1.0d
Short vol33%
DataJan 2020–Jul 2026
Filing10-Q · May 15
Equibles Rating
blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−46%
below
Price vs 50-day avg
−7%
below
RSI (14)
34
neutral
MACD trend
Negative
52-week position
18%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−10%
trailing
6-month return
−42%
trailing
YTD return
−48%
this year
Relative strength
−49%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.02% of float · ▲ +4.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
13
low risk · 0–100
Fundamentals
Revenue growth
−5%
Y/Y
Gross margin
113%
expanding
EPS growth
0%
Y/Y
Free cash flow
$-18.7K
Balance sheet
$87.0K
net cash
Quant / Vol
risk profile
Volatility
120%
annualized · 1-yr
Max drawdown
−72%
past year
ATR
5.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−46%
Bearish
Price vs 50-day avg
−7%
Bearish
RSI (14)
34
Neutral
MACD trend
Negative
Bearish
52-week position
18%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.02% of float · ▲ +4.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $0
Now $0 · 18%
52-wk high $0
vs 200-day avg -46%
vs 50-day avg -7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Non-GAAP Cash Operating Expenses non-GAAP | $1,415,226 | year ended December 31, 2025 | — |
| Non-GAAP Net Loss non-GAAP | $284,815 | year ended December 31, 2025 | — |
| Non-GAAP Operating Profit non-GAAP | $145,881 | year ended December 31, 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VYCO
this stock
Vycor Medical Inc
|
$2.10M | -47.9% | -4.7% | — | 0.0% |
|
ABT
Abbott Laboratories
|
$165.79B | -23.6% | +5.7% | 26.7 | 1.3% |
|
SYK
Stryker Corp
|
$125.30B | -6.8% | +11.2% | 37.8 | 1.6% |
|
MDT
Medtronic plc
|
$104.98B | -13.9% | +8.4% | 22.0 | 1.4% |
|
BSX
Boston Scientific Corp
|
$66.60B | -53.0% | +5.5% | 18.8 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VYCO | -4.6% | -10.0% | -41.7% | -4.6% | -47.9% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -4.4% | -10.8% | -49.1% | -4.4% | -57.2% |